50 related articles for article (PubMed ID: 16831415)
1. Effects of the intravenous administration of [Lys7]dermorphin on local cerebral glucose utilization in the rat.
Pontieri FE; Lattanzi R; Benincasa D; Cavallari M; Negri L; Orzi F
Eur J Pharmacol; 2006 Aug; 544(1-3):17-20. PubMed ID: 16831415
[TBL] [Abstract][Full Text] [Related]
2. Production of antinociception by peripheral administration of [Lys7]dermorphin, a naturally occurring peptide with high affinity for mu-opioid receptors.
Negri L; Lattanzi R; Melchiorri P
Br J Pharmacol; 1995 Jan; 114(1):57-66. PubMed ID: 7712029
[TBL] [Abstract][Full Text] [Related]
3. Respiratory and cardiovascular effects of the mu-opioid receptor agonist [Lys7]dermorphin in awake rats.
Negri L; Lattanzi R; Tabacco F; Melchiorri P
Br J Pharmacol; 1998 May; 124(2):345-55. PubMed ID: 9641552
[TBL] [Abstract][Full Text] [Related]
4. Cross-tolerance between dermorphin and morphine to analgesia and catalepsy in rats.
Broccardo M; Improta G
Peptides; 1985; 6 Suppl 3():165-9. PubMed ID: 3831961
[TBL] [Abstract][Full Text] [Related]
5. Dermorphin analog Tyr-D-Arg2-Phe-sarcosine-induced opioid analgesia and respiratory stimulation: the role of mu 1-receptors?
Paakkari P; Paakkari I; Vonhof S; Feuerstein G; Sirén AL
J Pharmacol Exp Ther; 1993 Aug; 266(2):544-50. PubMed ID: 8394909
[TBL] [Abstract][Full Text] [Related]
6. Effects of intra-VTA injection of neurotensin on local cerebral glucose utilization in freely moving rats.
Pontieri FE; Rasura M; Scontrini A; Buttarelli FR
Peptides; 2000 Nov; 21(11):1751-3. PubMed ID: 11090931
[TBL] [Abstract][Full Text] [Related]
7. Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor-mediated effect.
Paakkari P; Paakkari I; Sirén AL; Feuerstein G
J Pharmacol Exp Ther; 1990 Jan; 252(1):235-40. PubMed ID: 1967644
[TBL] [Abstract][Full Text] [Related]
8. Functional correlates of nicotine administration: similarity with drugs of abuse.
Pontieri FE; Passarelli F; Calò L; Caronti B
J Mol Med (Berl); 1998 Mar; 76(3-4):193-201. PubMed ID: 9535552
[TBL] [Abstract][Full Text] [Related]
9. Central mu opioid receptor-mediated changes in renal function in conscious rats.
Kapusta DR; Obih JC; Dibona GF
J Pharmacol Exp Ther; 1993 Apr; 265(1):134-43. PubMed ID: 8097241
[TBL] [Abstract][Full Text] [Related]
10. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians.
Stevens CW
J Pharmacol Exp Ther; 1996 Feb; 276(2):440-8. PubMed ID: 8632308
[TBL] [Abstract][Full Text] [Related]
11. Renal mu opioid receptor mechanisms in regulation of renal function in rats.
Kapusta DR; Jones SY; DiBona GF
J Pharmacol Exp Ther; 1991 Jul; 258(1):111-7. PubMed ID: 1677034
[TBL] [Abstract][Full Text] [Related]
12. II. Functional consequences of intragastrically administered ethanol in rats as measured by the 2-[14C]deoxyglucose method: the contribution of dopamine.
Williams-Hemby L; Porrino LJ
Alcohol Clin Exp Res; 1997 Dec; 21(9):1581-91. PubMed ID: 9438516
[TBL] [Abstract][Full Text] [Related]
13. Increased analgesic potency of mu agonists after continuous naloxone infusion in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1991 Nov; 259(2):582-9. PubMed ID: 1658305
[TBL] [Abstract][Full Text] [Related]
14. [Development of opioid tolerance -- molecular mechanisms and clinical consequences].
Freye E; Latasch L
Anasthesiol Intensivmed Notfallmed Schmerzther; 2003 Jan; 38(1):14-26. PubMed ID: 12522725
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanism for anti-analgesic action of agonists of the kappa-opioid receptor.
Pan ZZ; Tershner SA; Fields HL
Nature; 1997 Sep; 389(6649):382-5. PubMed ID: 9311779
[TBL] [Abstract][Full Text] [Related]
16. Dimeric dermorphin peptides: central administration suppresses gastric acid secretion through interaction with mu-type opioid receptor.
Guglietta A; Irons BJ; Lazarus LH; de Castiglione R; Melchiorri P
Methods Find Exp Clin Pharmacol; 1989 Nov; 11(11):663-70. PubMed ID: 2560103
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of ibogaine on local cerebral glucose utilization in drug-naive and morphine-dependent rats.
Levant B; Pazdernik TL
Brain Res; 2004 Apr; 1003(1-2):159-67. PubMed ID: 15019575
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of mu- and delta-opioid receptor antagonists.
Abul-Husn NS; Sutak M; Milne B; Jhamandas K
Br J Pharmacol; 2007 Jul; 151(6):877-87. PubMed ID: 17502848
[TBL] [Abstract][Full Text] [Related]
19. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia.
Chen SR; Pan HL
J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418
[TBL] [Abstract][Full Text] [Related]
20. Alteration of local cerebral glucose utilization following intravenous administration of heroin in Fischer 344 rats.
Martin TJ; Miller M; Dworkin SI; Smith JE; Porrino LJ
Brain Res; 1997 May; 755(2):313-8. PubMed ID: 9175898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
